Case management of the anemic patient. Epoetin alfa: focus on reimbursement.
Epoetin alfa therapy has been proven effective in treating anemia in dialysis patients; it increases the hematocrit (HCT) and improves the quality of life. The reimbursement policy for Epoetin alfa therapy is very important to dialysis patients; nurses need to understand the policy to help patients with reimbursement and to comply with the provisions for patient monitoring and education.
Roe
W I
WI
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology / Q000451:nursing; D004921:Erythropoietin / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000191:economics; D008297:Male; D008875:Middle Aged; D012051:Reimbursement Mechanisms; D012646:Self Administration
D004921:Erythropoietin